![]() ![]() develops recommendations on messages for stakeholders.gathers information that will help in mitigation efforts.determines if the shortage for a drug or group of drugs is Tier 3 (the most serious level).assesses the scale and potential impact of a shortage.This committee is made up of federal and provincial/territorial governments and health care representatives. When a shortage has the potential to pose a significant risk to patients and the health care system, DSD assembles a Tier Assignment Committee (TAC). work together on strategies to prevent shortages and strengthen the supply chain.ensure there is timely and effective communication between all potentially impacted groups.identify options to mitigate the impact of drug shortages.When an anticipated or actual drug shortage may have a national impact, the division works with companies and other stakeholders to : Health Canada has a Drug Shortages Division (DSD) that plays a leadership role in addressing drug shortages. Team members work together to gather details of a shortage, share information and coordinate mitigation and management strategies. It coordinates communication around confirming and assessing the status and details of a shortage. The Provincial/Territorial Drug Shortages Task Team is another group. Refer to the multi-stakeholder toolkit (PDF document) for a description of the roles and responsibilities of supply chain players, and the tools and strategies available to address drug shortages. Health Canada co-chairs the MSSC, along with a rotating provincial/territorial co-chair. Health Canada works with these important players to take action on shortages. The MSSC brings together representatives of industry associations, federal, provincial and territorial governments, and health care professional associations to mitigate and prevent drug shortages. To this end, the Multi-Stakeholder Steering Committee on Drug Shortages (MSSC) was established in 2012. These include provinces and territories, manufacturers, distributors, health care professionals and the federal government. We are committed to doing our part to address these shortages as they occur.Īddressing drug shortages is the responsibility of many stakeholders. Health Canada recognizes that drug shortages can have a negative impact on patients, caregivers, health care providers and the health care system. Health Canada plays an active role as the federal regulator in assessing drugs and other health products on the Canadian market for safety, efficacy and quality. Decisions on which medications to prescribe are made by health care providers, working together with patients when appropriate.Įnsuring that Canada's patients can get the medicines they need is a top priority for the Government of Canada. The decision to produce, market and sell drugs in Canada are made by drug companies. difficulty obtaining raw materials and ingredientsĭrug shortages are the responsibility of many stakeholders.Governments, supply chain players and health care providers work together to mitigate or minimize the impact of shortages when possible.Ī drug shortage can last a short time or a long time. In some cases, drug shortages are mitigated and patients don't experience any difficulty obtaining their drugs.įor certain drugs, manufacturers are required by law to report anticipated and actual drug shortages and discontinuations on the shortage reporting website. When there's a drug shortage, patients should consult with their pharmacists and doctors about other potential treatment options. A shortage may also cause a delay in a drug's availability as it flows through the supply chain. For patients in Canada, this may mean they don't have access to the drug because it's on back-order or 'stock-out' ( depleted entirely). The words drug, medication and medicine are often used interchangeably. ![]() How to check the drug shortage reporting websiteĪ drug shortage is when a drug manufacturer isn't able to supply enough of a drug to meet all of its Canadian orders on time.What to do if you believe your medication is in shortage.Improving access to drugs and other health products.Learn more about the consultation, which closes on August 4, 2023: improved communication and transparency.Our focus for this consultation is around 4 key areas for action: ![]() On June 8, 2023, we launched a consultation to hear from Canadians and other stakeholders on how to improve the availability of drugs and health products. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |